NeuroSense Therapeutics Ltd. Analysis
| Analyst Ratings |
|
Average Target Price
|
7.00
|
|
Average Rating
|
4.00
|
|
# Strong Buys
|
0
|
|
# Buys
|
1
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-12-31
|
-0.28
|
0.00
|
0.28
|
100.00%
|
|
2022-09-30
|
-0.28
|
-0.26
|
0.02
|
7.14%
|
|
2022-06-30
|
-0.28
|
-0.30
|
-0.02
|
-7.14%
|
|
2022-03-31
|
-0.21
|
-0.24
|
-0.03
|
-14.29%
|
|
2021-12-31
|
-0.16
|
-0.16
|
0.00
|
0.00%
|
|
2021-09-30
|
-0.21
|
-0.25
|
-0.04
|
-19.05%
|
|
2021-03-31
|
0.00
|
-0.27
|
-0.27
|
0.00%
|
|
2020-12-31
|
0.00
|
-0.27
|
-0.27
|
0.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.80
|
|
2021-12-31
|
-0.68
|
|
2020-12-31
|
-0.72
|
|
2019-12-31
|
-0.06
|